#2 - Organigram (NASDAQ:OGI)
Organigram (NASDAQ:OGI) is one of the weaker performers among cannabis stocks this year. OGI stock is down nearly 50% this year. And the bigger problem is that this is not a new occurrence. The stock has been a laggard for the better part of four years. Some of this has to do with legal marijuana’s inability to compete with the Canadian black market.
In 2020, much of that has to do with its inability to capitalize on the Cannabis 2.0 movement in its home country of Canada. So what makes the company an appealing option? The short answer is volume.
Organigram is one of the largest cannabis producers in Canada. And that gives it a chance. But first, the company has had to go through a significant restructuring. That seems nearly complete. To be sure, the company will have a lot of ground to make up. Organigram is a contrarian play, but not an altogether foolish one.
About Organigram
Organigram Holdings Inc, through its subsidiaries, engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, gummies, and concentrates for medical retailers; adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co, Edison JOLTS, Tremblant, and Laurentian brands.
Read More - Current Price
- $1.52
- Consensus Rating
- Buy
- Ratings Breakdown
- 2 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
- Consensus Price Target
- N/A
